Here we studied the activity of α-bisabolol against BCR-ABL+ cells using 3 cell lines (K562, LAMA-84, CML-T1) and 10 primary BCR-ABL+ ALL samples. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.